Overexpression of CA9 correlates with tumour progression, metastasis, and poor prognosis in cancers including renal carcinomas, cervical squamous carcinomas, oesophageal carcinomas, bladder carcinomas and non-small cell lung carcinomas [37]. Here, CA9 is linked to non-small cell lung carcinoma.